跳到主要内容

MAXCYTE, INC. (MXCT) Stock Forecast 2025 - AI Price Prediction & Analysis


MAXCYTE, INC. (MXCT) AI Stock Price Forecast & Investment Analysis

MAXCYTE, INC. Stock Price Chart and Technical Analysis

Loading MAXCYTE, INC. interactive price chart and technical analysis...

MAXCYTE, INC. (MXCT) - Comprehensive Stock Analysis & Investment Research

Deep dive into MAXCYTE, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about MAXCYTE, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For MAXCYTE, INC.: MAXCYTE, INC. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

MAXCYTE, INC. (Stock Symbol: MXCT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Commercial Physical & Biological Research industry.

The organization employs approximately 2021 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing MAXCYTE, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For MAXCYTE, INC.: With $35M in annual revenue and -78.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $35 million generating a -78.4% net profit margin .

Market Capitalization: $150 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -6.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for MAXCYTE, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For MAXCYTE, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for MAXCYTE, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: MAXCYTE, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For MAXCYTE, INC.: Market positioning analysis based on available financial and operational metrics.

MAXCYTE, INC. strategically competes in the highly dynamic Services-Commercial Physical & Biological Research marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 86.0% gross margin, indicating strong pricing power and operational efficiency.

MAXCYTE, INC. (MXCT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for MAXCYTE, INC. stock analysis.

Loading MAXCYTE, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into MAXCYTE, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if MAXCYTE, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For MAXCYTE, INC.: With a P/E ratio of -10.56, the market sees the stock as potentially undervalued.

P/E Ratio -10.56x
P/B Ratio 0.79x
Market Cap $150M
EPS $-0.42
Book Value/Share $1.79
Revenue/Share $0.34
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently MAXCYTE, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For MAXCYTE, INC.: An ROE of -6.1% indicates room for improvement in shareholder value creation.

ROE -6.1%
ROA -5.5%
ROIC -5.8%
Gross Margin 86.0%
Operating Margin -101.7%
Net Margin -78.4%
EBT Margin -41.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess MAXCYTE, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For MAXCYTE, INC.: A current ratio of 17.09 indicates strong liquidity.

Current Ratio 17.09x
Quick Ratio 16.53x
D/E Ratio 0.05x
Financial Leverage 1.11x
Interest Coverage -52.1x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal MAXCYTE, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For MAXCYTE, INC.: Free cash flow of $-19M indicates cash challenges that need attention.

Operating Cash Flow $-10M
Free Cash Flow $-19M
Capital Spending $-10M
FCF/Sales -49.4%
CapEx/Sales 24.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively MAXCYTE, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For MAXCYTE, INC.: An asset turnover of 0.13x suggests room for improvement in asset utilization.

Asset Turnover 0.13x
Receivables Turnover 3.6x
Inventory Turnover 0.6x
Fixed Assets Turnover 1.6x
Days Sales Outstanding 101 days
Days Inventory 598 days
Payables Period 397 days
Cash Conversion Cycle 302 days
Understanding Financial Statement Data

What these metrics mean: Key figures from MAXCYTE, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For MAXCYTE, INC.: With annual revenue of $35M, MAXCYTE, INC. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $35M
R&D Expense $23M
SG&A Expense $93M
Cost of Goods Sold $6M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 91%
Cash & Short-term Investments 85%
Total Liabilities 10%
Accounts Receivable 4%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 107M
Growth Metrics (YoY)
EPS Growth -4.5%

Latest MAXCYTE, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting MAXCYTE, INC. (MXCT) stock price and investment outlook.

, source: The Motley Fool

MaxCyte, Inc. (MXCT -2.47%) Q1 2022 Earnings Call May 09, 2022, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, and thank you ...

, source: Seeking Alpha

MaxCyte, Inc. (NASDAQ: MXCT) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Sean Menarguez - Head-IR Doug Doerfler - President and CEO Douglas Swirsky - CFO ...

MAXCYTE, INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of MAXCYTE, INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABSI Unlock Forecast - 30 Days FREE Trial $351M -4.7x 1.8x
BIAF Unlock Forecast - 30 Days FREE Trial $7M -1.1x 3.7x
BIAFW Unlock Forecast - 30 Days FREE Trial $9M x 3.0x
CBIH Unlock Forecast - 30 Days FREE Trial $7M x x
CRL Unlock Forecast - 30 Days FREE Trial $8226M 19.3x 2.5x
FOXO Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ICLR Unlock Forecast - 30 Days FREE Trial $14267M 14.5x 1.5x
INCY Unlock Forecast - 30 Days FREE Trial $16994M 19.5x 4.1x
IQV Unlock Forecast - 30 Days FREE Trial $33290M 26.9x 5.8x
ISPC Unlock Forecast - 30 Days FREE Trial $3M -2.2x 1.6x
LUNA Unlock Forecast - 30 Days FREE Trial $61M 45.3x 0.7x
MEDP Unlock Forecast - 30 Days FREE Trial $14844M 35.5x 86.1x
MXCT Unlock Forecast - 30 Days FREE Trial $150M -10.6x 0.8x
NOTV Unlock Forecast - 30 Days FREE Trial $56M -1.3x 0.4x
NRC Unlock Forecast - 30 Days FREE Trial $356M 19.8x 16.7x
OABI Unlock Forecast - 30 Days FREE Trial $210M -6.5x 0.8x
OABIW Unlock Forecast - 30 Days FREE Trial $63M x 0.2x
ONMD Unlock Forecast - 30 Days FREE Trial $18M x -1.1x
ONMDW Unlock Forecast - 30 Days FREE Trial $1M x -0.1x

Frequently Asked Questions - MAXCYTE, INC. Stock Forecast

How accurate are MAXCYTE, INC. stock predictions?

Our AI model demonstrates 44% historical accuracy for MXCT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence MAXCYTE, INC. stock price forecasts?

Our analysis considers MAXCYTE, INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is MAXCYTE, INC. a good investment in 2025?

Based on our AI analysis, MAXCYTE, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are MAXCYTE, INC. forecasts updated?

MAXCYTE, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced MAXCYTE, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for MAXCYTE, INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...